Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages

Volume 20, Issue 1, December 2024 .

Source: Human Vaccines and Immunotherapeutics - April 5, 2024 Category: Allergy & Immunology Authors: Bradley K. AckersonKatia J. BruxvoortLei QianLina S. SySijia QiuJulia E. TubertGina S. LeeJennifer H. KuAna FloreaYi LuoRadha BathalaJulie SternSoon K. ChoiHarpreet S. TakharMichael AragonesMorgan A. MarksEvan J. AndersonCindy Ke ZhouTianyu SunCarla A. Ta Source Type: research